Here are four notes:
1. The analysts have a 12-month price target of $22.44 on Surgery Partner shares.
2. Zacks recently upgraded company shares form a “sell” to a “buy” rating.
3. On Oct. 11, Surgery Partners shares plummeted 1.11 percent, trading at $19.98 per share.
4. The company has a 50-day moving average of $19.33 and 200-day moving average of $16.69.
More articles on surgery centers:
Jefferies analysts weigh in on SCA shares: 3 notes
Surgical Care Affiliates to refinance term loan facility and obtain incremental term loan: 4 thoughts
3 recent ASC acquisitions — October 6, 2016
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.